About Evidose
Evidose is a company based in Wilmington (United States) founded in 2023 by Anna Litwinska and Kacper Zambrzycki. Evidose has raised $500 thousand across 1 funding round from investors including Inovo Venture Partners and 500 Global. Evidose offers products and services including Clinical Trial Platform and Trial Effectiveness Services. Evidose operates in a competitive market with competitors including Nutrino, Edamam, MenuTrinfo, ESHA Research and Nutrition Integrated, among others.
- Headquarter Wilmington, United States
- Founders Anna Litwinska, Kacper Zambrzycki
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Evidose Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$500 K (USD)
in 1 rounds
-
Latest Funding Round
$500 K (USD), Seed
Nov 29, 2023
-
Investors
Inovo Venture Partners
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Evidose
Evidose offers a comprehensive portfolio of products and services, including Clinical Trial Platform and Trial Effectiveness Services.
Provides tools to optimize clinical trial processes and results
Offers expert support for improving clinical research efficiency
Funding Insights of Evidose
Evidose has successfully raised a total of $500K through 1 strategic funding round. The most recent funding activity was a Seed round of $500 thousand completed in November 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Evidose
Evidose has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Inovo Venture Partners and 500 Global.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech-focused venture capital firm
|
Locked | Locked | Locked | |
|
Venture capital and acceleration are provided to tech startups.
|
Locked | Locked | Locked |
Investor details for Evidose
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Evidose
Investment portfolio details for Evidose
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Evidose
Detailed financials for Evidose
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Evidose Comparisons
Peer comparison for Evidose
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Evidose
Evidose operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nutrino, Edamam, MenuTrinfo, ESHA Research and Nutrition Integrated, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of nutrition-based data services and analytics technology
|
|
| Locked | Locked | Locked |
Provider of a cloud-based semantic technology platform that aggregates recipes
|
|
| Locked | Locked | Locked |
Provides accredited food allergy training, certifications, and nutritional analysis services.
|
|
| Locked | Locked | Locked |
Provides software for food compliance, formulation, and traceability solutions.
|
|
| Locked | Locked | Locked |
Provides data-driven insights and solutions for active nutrition businesses.
|
Detailed competitors of Evidose
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Evidose
Complete news archive for Evidose
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Evidose
Evidose was founded in 2023.
Evidose is headquartered in Wilmington, United States. It is registered at Wilmington, Delaware, United States.
Anna Litwinska is the current CEO of Evidose. They have also founded this company.
Evidose is a funded company, having raised a total of $500K across 1 funding round to date.
Evidose was founded in 2023 and is based in Wilmington, United States. A platform is maintained to deliver scientifically robust data tailored for the supplement and pharmaceutical industries. Data-driven insights are supplied to support the wellness sector, where transparency and analytical rigor are applied to supplements and nutraceuticals. The company is co-led by Anna Litwinska as CEO and Kacper Zambrzycki as COO.
Evidose's top competitors include Nutrino, Edamam and MenuTrinfo.
Evidose offers Clinical Trial Platform and Trial Effectiveness Services.
Evidose has 2 investors. Key investors include Inovo Venture Partners, and 500 Global.